The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Fintel reports that on October 31, 2024, Wells Fargo initiated coverage of ORIC Pharmaceuticals (NasdaqGS:ORIC) with a Overweight recommendation. As of October 22, 2024, the average one-year price ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Oric Pharmaceuticals Inc. has reached a new 52-week high, with its stock price climbing to 14.89 USD. This milestone marks a significant achievement for the $1.4B market cap company, reflecting a ...
ORIC Pharmaceuticals (NASDAQ: ORIC) is a small-cap pharma stock. It aims to make a difference with its potentially "best-in-class" treatments. The company’s shares have not had a great year, returning ...
SOUTH SAN FRANCISCO, Calif. - ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC), a company engaged in the development of oncology treatments, has presented new data on two of its drug candidates at the ...
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. ORIC Pharmaceuticals (ORIC) updated investors on Phase 1b data for rinzimetostat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results